CONSUELO SANCLEMENTE: Open Payments
NPI 1972185163 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$870 in 8 payments from 8 companies in 2025. Trend: 2023 $664 · 2024 $423 · 2025 $870
Food & beverage: $870
| Company | Payments | Amount |
|---|---|---|
| Aimmune Therapeutics, Inc. | 1 | $125 |
| Phathom Pharmaceuticals, Inc. | 1 | $125 |
| ABBVIE INC. | 1 | $125 |
| Janssen Biotech, Inc. | 1 | $125 |
| Novo Nordisk Inc | 1 | $118 |
| Celltrion USA Inc. | 1 | $114 |
| Ardelyx, Inc. | 1 | $110 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $28 |
Products named: ZENPEP, VOQUEZNA, SKYRIZI, TREMFYA, Wegovy, ZYMFENTRA, IBSRELA, ENTYVIO.
Industry payments across FL — which companies pay providers there.
